SLN
Price
$5.75
Change
-$0.12 (-2.04%)
Updated
Jan 15, 12:04 PM (EDT)
Capitalization
170.04M
62 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$4.99
Change
-$0.05 (-0.99%)
Updated
Jan 15, 12:17 PM (EDT)
Capitalization
1.38B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLN vs TSHA

Header iconSLN vs TSHA Comparison
Open Charts SLN vs TSHABanner chart's image
Silence Therapeutics
Price$5.75
Change-$0.12 (-2.04%)
Volume$700
Capitalization170.04M
Taysha Gene Therapies
Price$4.99
Change-$0.05 (-0.99%)
Volume$1.3K
Capitalization1.38B
SLN vs TSHA Comparison Chart in %
SLN
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLN vs. TSHA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLN is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (SLN: $5.87 vs. TSHA: $5.04)
Brand notoriety: SLN and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLN: 123% vs. TSHA: 69%
Market capitalization -- SLN: $170.04M vs. TSHA: $1.38B
SLN [@Biotechnology] is valued at $170.04M. TSHA’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLN’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • SLN’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, both SLN and TSHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • SLN’s TA Score: 4 bullish, 6 bearish.
  • TSHA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than SLN.

Price Growth

SLN (@Biotechnology) experienced а +1.21% price change this week, while TSHA (@Biotechnology) price change was -5.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

SLN is expected to report earnings on Mar 18, 2026.

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.38B) has a higher market cap than SLN($170M). SLN YTD gains are higher at: -3.454 vs. TSHA (-8.364). SLN has higher annual earnings (EBITDA): -81.06M vs. TSHA (-98.71M). TSHA has more cash in the bank: 297M vs. SLN (102M). SLN has less debt than TSHA: SLN (182K) vs TSHA (69M). SLN has higher revenues than TSHA: SLN (25.8M) vs TSHA (6.31M).
SLNTSHASLN / TSHA
Capitalization170M1.38B12%
EBITDA-81.06M-98.71M82%
Gain YTD-3.454-8.36441%
P/E RatioN/A2.70-
Revenue25.8M6.31M409%
Total Cash102M297M34%
Total Debt182K69M0%
TECHNICAL ANALYSIS
Technical Analysis
SLNTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
SLN
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDIVX18.930.08
+0.42%
Janus Henderson International Div I
AMINX71.30N/A
N/A
Amana Income Institutional
PGBHX42.04-0.44
-1.04%
Principal Blue Chip R6
STPCX9.89-0.11
-1.10%
Saratoga Technology & Comm C
JAGRX64.51-0.99
-1.51%
Janus Henderson VIT Research Instl

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-0.68%
CLLS - SLN
43%
Loosely correlated
+0.47%
CMVLF - SLN
38%
Loosely correlated
N/A
TSHA - SLN
38%
Loosely correlated
+2.86%
PCVX - SLN
36%
Loosely correlated
+5.41%
IMTX - SLN
36%
Loosely correlated
+4.80%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+2.86%
PCVX - TSHA
51%
Loosely correlated
+5.41%
NGNE - TSHA
50%
Loosely correlated
+10.91%
RGNX - TSHA
47%
Loosely correlated
-0.66%
SLDB - TSHA
44%
Loosely correlated
+12.60%
BCYC - TSHA
43%
Loosely correlated
+2.00%
More